New drug cuts severe COPD flare-ups by 30%, study shows

A new experimental drug called tozarocumab is showing promise in reducing flare-ups for COPD patients who do not respond fully to inhalers. Additionally, recent research suggests that laughter therapy may be as effective as traditional breathing exercises in helping patients manage their symptoms and improve lung function.